RAC 3.31% $1.61 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-68

  1. 2,671 Posts.
    lightbulb Created with Sketch. 2407
    They've applied it in a cell line that's unresponsive to the immune therapy - take a deeper look
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.